首页> 美国卫生研究院文献>Nucleic Acids Research >2′-Deoxyriboguanylurea the primary breakdown product of 5-aza-2′-deoxyribocytidine is a mutagen an epimutagen an inhibitor of DNA methyltransferases and an inducer of 5-azacytidine-type fragile sites
【2h】

2′-Deoxyriboguanylurea the primary breakdown product of 5-aza-2′-deoxyribocytidine is a mutagen an epimutagen an inhibitor of DNA methyltransferases and an inducer of 5-azacytidine-type fragile sites

机译:5-氮杂-2-脱氧核糖胞苷的主要分解产物2-脱氧核糖鸟嘌呤是一种诱变剂一种表观诱变剂DNA甲基转移酶的抑制剂和5-氮杂胞苷类脆弱位点的诱导剂。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

5-Aza-2′-deoxycytidine (5azaC-dR) has been employed as an inhibitor of DNA methylation, a chemotherapeutic agent, a clastogen, a mutagen, an inducer of fragile sites and a carcinogen. However, its effects are difficult to quantify because it rapidly breaks down in aqueous solution to the stable compound 2′-deoxyriboguanylurea (GuaUre-dR). Here, we used a phosphoramidite that permits the introduction of GuaUre-dR at defined positions in synthetic oligodeoxynucleotides to demonstrate that it is a potent inhibitor of human DNA methyltransferase 1 (hDNMT1) and the bacterial DNA methyltransferase (M.EcoRII) and that it is a mutagen that can form productive base pairs with either Guanine or Cytosine. Pure GuaUre-dR was found to be an effective demethylating agent and was able to induce 5azaC-dR type fragile sites FRA1J and FRA9E in human cells. Moreover, we report that demethylation associated with C:G → G:C transversion and C:G → T:A transition mutations was observed in human cells exposed to pure GuaUre-dR. The data suggest that most of the effects attributed to 5azaC-dR are exhibited by its stable primary breakdown product.
机译:5-Aza-2'-脱氧胞苷(5azaC-dR)已被用作DNA甲基化的抑制剂,化学治疗剂,弹性蛋白酶,诱变剂,脆弱部位的诱导剂和致癌物。然而,由于其在水溶液中迅速分解成稳定的化合物2'-脱氧核糖鸟嘌呤脲(GuaUre-dR),因此其作用难以量化。在这里,我们使用亚磷酰胺,允许在合成的寡脱氧核苷酸的指定位置引入GuaUre-dR,以证明它是人类DNA甲基转移酶1(hDNMT1)和细菌DNA甲基转移酶(M.EcoRII)的有效抑制剂,并且可以与鸟嘌呤或胞嘧啶形成生产性碱基对的诱变剂。发现纯GuaUre-dR是有效的脱甲基剂,能够在人细胞中诱导5azaC-dR型脆弱位点FRA1J和FRA9E。此外,我们报道在暴露于纯GuaUre-dR的人类细胞中观察到与C:G→G:C转化和C:G→T:A转换突变相关的脱甲基。数据表明,归因于5azaC-dR的大多数效应均由其稳定的主要分解产物表现出来。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号